A new randomized, double-blind, placebo-controlled clinical study found that participants who took Calocurb for 24 weeks lost an average of 8.3 pounds (3.77 kg), compared with 0.88 pounds (0.4 kg) among those who received a placebo
Those transitioning from less than 30 units of basal insulin would be started on 15 units of iGlarlixi
These include focusing on hydration and fluid intake, incorporating stretching and exercise into daily routines, and considering medical interventions and treatment options
Real-time, on-demand clinical visits or in-person care
Retatrutide, an experimental weight-loss drug, has not been approved by the FDA
Always communicate with your healthcare provider about any new or worsening symptoms to ensure the best possible management of your health